Colospan is a clinical stage company developing novel medical device aiming to alleviate the profound clinical and economic burden of anastomotic leaks and diverting colonic stomas following colorectal surgeries. The company’s lead product, CE approved in Europe, is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal content and the anastomotic site.